Arbutus Biopharma Corp. (ABUS)
4.29
-0.16
(-3.60%)
USD |
NASDAQ |
Mar 27, 16:00
4.30
+0.01
(+0.23%)
After-Hours: 20:00
Arbutus Biopharma Free Cash Flow : -39.72M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Moderna, Inc. | -2.075B |
| Merck & Co., Inc. | 12.36B |
| Pfizer Inc. | 9.076B |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.226M |
| Cash from Investing (Quarterly) | -1.588M |
| Cash from Financing (Quarterly) | 1.589M |
| Free Cash Flow Per Share (Quarterly) | -0.022 |
| Free Cash Flow to Equity (Quarterly) | -3.808M |
| Free Cash Flow to Firm (Quarterly) | -4.208M |
| Free Cash Flow Yield | -4.83% |